QRH-882260 Heptapeptide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for QRH-882260 Heptapeptide, covering 2017-12-06 to 2018-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of QRH-882260 Heptapeptide Application in the Colon [Phase 1]